Elite Pharmaceuticals Inc (ELTP)

[Couch]

If you do some solid DD you realize the risky period was in 2011 when Elite had Lodrane D pulled from the market. The company now has 5 products on the market.....2 additional doses of Phentermine Capsules launching by the end of the month.....Naltrexone pending FDA approval of site move, a 100% owned Anda pending approval and several other products including NDA's in development. Here is the list in Elite's pipeline.
http://www.elitepharma.com/product_pipeline.asp

There is little risk involved at this point in time witnessed by the most recent SEC quarterly report"

Consolidated revenues were $0.6 million for the quarter, an increase of 131% when compared to the comparable quarter of the prior year. This increase is the result of the continuing growth of the new revenue streams that have been created within the last eighteen months.

Just like previously, that requires us to get to an annual run rate of a little over $4 million, and Carter can correct me if I'm wrong about that, but I think that's correct. We are getting there; we're definitely getting there. With a little help from the FDA, we will get there in fiscal 2013.